Therapeutic Neovascularization–Quo Vadis?
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Dordrecht :
Springer Netherlands,
2007.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease
- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis
- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction
- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword
- Pampering and Priming the Heart
- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization
- Integrative Pro-angiogenic Activation: HIF-?
- The Maturation of Vessels – A Limitation to Forced Neovascularization?
- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads
- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis
- The Biology of Embryonic and Adult Endothelial Progenitor Cells
- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin
- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.